Richard Vosser
Stock Analyst at JP Morgan
(1.41)
# 3,616
Out of 5,113 analysts
16
Total ratings
55.56%
Success rate
-0.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOLN Molecular Partners AG | Maintains: Neutral | $4 → $3.75 | $4.07 | -7.86% | 3 | Dec 8, 2025 | |
| GRFS Grifols | Maintains: Neutral | $10 | $9.22 | +8.52% | 1 | Dec 8, 2025 | |
| SNY Sanofi | Downgrades: Neutral | n/a | $46.67 | - | 4 | Dec 8, 2025 | |
| NVS Novartis AG | Upgrades: Overweight | n/a | $146.15 | - | 1 | Dec 8, 2025 | |
| NVO Novo Nordisk | Upgrades: Overweight | n/a | $63.51 | - | 7 | Jun 7, 2022 |
Molecular Partners AG
Dec 8, 2025
Maintains: Neutral
Price Target: $4 → $3.75
Current: $4.07
Upside: -7.86%
Grifols
Dec 8, 2025
Maintains: Neutral
Price Target: $10
Current: $9.22
Upside: +8.52%
Sanofi
Dec 8, 2025
Downgrades: Neutral
Price Target: n/a
Current: $46.67
Upside: -
Novartis AG
Dec 8, 2025
Upgrades: Overweight
Price Target: n/a
Current: $146.15
Upside: -
Novo Nordisk
Jun 7, 2022
Upgrades: Overweight
Price Target: n/a
Current: $63.51
Upside: -